Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune responses to malignancies
Theresa L. Whiteside
Journal of Allergy and Clinical Immunology (2010) Vol. 125, Iss. 2, pp. S272-S283
Open Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

Tumor-Derived Exosomes and Their Role in Cancer Progression
Theresa L. Whiteside
Advances in clinical chemistry (2016), pp. 103-141
Open Access | Times Cited: 648
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
T WHITESIDE
Seminars in Cancer Biology (2005) Vol. 16, Iss. 1, pp. 3-15
Closed Access | Times Cited: 480
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw, Sara E. Kost, Juzer Kakal, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 11, pp. 3022-3029
Open Access | Times Cited: 424
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta, Hans Christian Probst, Van Vuong, et al.
The Journal of Immunology (2012) Vol. 189, Iss. 2, pp. 558-566
Open Access | Times Cited: 407
Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer
Sonja Ludwig, Theofanis Floros, Marie‐Nicole Theodoraki, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 16, pp. 4843-4854
Open Access | Times Cited: 302
The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer
Dermot S. O’Callaghan, Dearbhaile M. O’Donnell, Finbarr O’Connell, et al.
Journal of Thoracic Oncology (2010) Vol. 5, Iss. 12, pp. 2024-2036
Open Access | Times Cited: 281
What are regulatory T cells (Treg) regulating in cancer and why?
Theresa L. Whiteside
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 264
Radiation and immunotherapy: a synergistic combination
Anusha Kalbasi, Carl H. June, Naomi B. Haas, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 7, pp. 2756-2763
Open Access | Times Cited: 254
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
Linda M. Liau, Keyoumars Ashkan, Steven Brem, et al.
JAMA Oncology (2022) Vol. 9, Iss. 1, pp. 112-112
Open Access | Times Cited: 233
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
Arsen Osipov, May Tun Saung, Lei Zheng, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Immune-related adverse events in older adults receiving immune checkpoint inhibitors: a comprehensive analysis of the Food and Drug Administration Adverse Event Reporting System
Buğra Han Esen, Şevval Nur Bektaş, A. Umur Topçu, et al.
Age and Ageing (2025) Vol. 54, Iss. 1
Open Access | Times Cited: 2
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential
Y Lu
Advanced Drug Delivery Reviews (2004) Vol. 56, Iss. 8, pp. 1161-1176
Closed Access | Times Cited: 239
Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells
Li-Yuan Chang, Yung‐Chang Lin, Jayashri Mahalingam, et al.
Cancer Research (2012) Vol. 72, Iss. 5, pp. 1092-1102
Open Access | Times Cited: 211
Important aspects of Toll-like receptors, ligands and their signaling pathways
Z L Chang
Inflammation Research (2010) Vol. 59, Iss. 10, pp. 791-808
Closed Access | Times Cited: 209
CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe
David E. Gilham, Reno Debets, Martin Pulé, et al.
Trends in Molecular Medicine (2012) Vol. 18, Iss. 7, pp. 377-384
Closed Access | Times Cited: 174
A systematic review of the association between immunogenomic markers and cancer-related fatigue
Leorey N. Saligan, H.S. Kim
Brain Behavior and Immunity (2012) Vol. 26, Iss. 6, pp. 830-848
Open Access | Times Cited: 154
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Trina J. Stewart, Mark J. Smyth
Cancer and Metastasis Reviews (2011) Vol. 30, Iss. 1, pp. 125-140
Open Access | Times Cited: 144
Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer
Derrick Wansom, Emily Light, Dafydd Thomas, et al.
The Laryngoscope (2011) Vol. 122, Iss. 1, pp. 121-127
Open Access | Times Cited: 125
Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
Taku Fujimura, Sabine Ring, Viktor Umansky, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 4, pp. 1239-1246
Open Access | Times Cited: 124
CXCL13/CXCR5 signaling axis in cancer
Muzammal Hussain, Dickson Adah, Muqddas Tariq, et al.
Life Sciences (2019) Vol. 227, pp. 175-186
Closed Access | Times Cited: 124
Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma
Hideyuki Takahashi, Koichi Sakakura, Reika Kawabata‐Iwakawa, et al.
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 11, pp. 1407-1417
Open Access | Times Cited: 120
The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
Kwan Ho Lee, Eun Young Kim, Ji Sup Yun, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 113
Inflammation and tuberculosis: host‐directed therapies
Alimuddin Zumla, Martin Rao, Shreemanta K. Parida, et al.
Journal of Internal Medicine (2014) Vol. 277, Iss. 4, pp. 373-387
Open Access | Times Cited: 112
Peripheral Blood Immune Cell Methylation Profiles Are Associated with Nonhematopoietic Cancers
Devin C. Koestler, Carmen J. Marsit, Brock C. Christensen, et al.
Cancer Epidemiology Biomarkers & Prevention (2012) Vol. 21, Iss. 8, pp. 1293-1302
Open Access | Times Cited: 112
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
Taku Fujimura, Yumi Kambayashi, Setsuya Aiba
OncoImmunology (2012) Vol. 1, Iss. 8, pp. 1433-1434
Open Access | Times Cited: 107
Page 1 - Next Page

Scroll to top